An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission
- PMID: 33295073
- PMCID: PMC8049017
- DOI: 10.1002/hpm.3095
An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission
Abstract
The fast spread of coronavirus disease 2019 (COVID-19) constitutes a worldwide challenge to the public health, educational and trade systems, affecting the overall well-being of human societies. The high transmission and mortality rates of this virus, and the unavailability of a vaccine or treatment, resulted in the decision of multiple governments to enact measures of social distancing. Such measures can reduce the exposure to bioaerosols, which can result in pathogen deposition in the respiratory tract of the host causing disease and an immunological response. Thus, it is important to consider the validity of the proposal for keeping a distance of at least 2 m from other persons to avoid the spread of COVID-19. This work reviews the effect of aerodynamic diameter (size) of particles carrying RNA copies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A SARS-CoV-2 carrier person talking, sneezing or coughing at distance of 2 m can still provide a pathogenic bioaerosol load with submicron particles that remain viable in air for up to 3 h for exposure of healthy persons near and far from the source in a stagnant environment. The deposited bioaerosol creates contaminated surfaces, which if touched can act as a path to introduce the pathogen by mouth, nose or eyes and cause disease.
Keywords: COVID-19; SARS-CoV-2; aerodynamic size; bioaerosol; infection; social distancing; virus.
© 2020 The Authors. The International Journal of Health Planning and Management published by John Wiley & Sons Ltd.
Conflict of interest statement
The author declares no conflict of interest. The funder had no role in the design of the study, or interpretation of data; in the writing of the manuscript, or in the decision to publish this material.
Figures
References
-
- WHO . Coronavirus Disease (COVID‐19) Pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed March 25, 2020.
-
- WHO . WHO Director‐General's opening remarks at the media briefing on COVID‐19 ‐ 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re.... Accessed March 25, 2020.
-
- Coronavirus COVID‐19 global cases. https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd4029942.... Accessed March 25, 2020.
-
- Interim Pre‐Pandemic Planning Guidance: Community strategy for pandemic influenza mitigation in the United States—early, targeted, layered use of nonpharmaceutical interventions. Centers for Disease Control and Prevention; 2007.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
